AN UPDATE ON DIAGNOSIS AND MANAGEMENT OF THROMBOEMBOLISM IN PREGNANCY

S ULLAH; K FAWAD; N SHAHBAZ; N KHAN; KS KHAN; H KHAN

doi:10.54112/bcsrj.v2024i1.1096

Authors

S ULLAH Lady Reading Hospital Peshawar, Pakistan
K FAWAD Department of Gynecology and Obstetrics, Lady Reading Hospital, Peshawar, Pakistan
N SHAHBAZ Department of obstetrics and gynecology, Woman and children type c hospital karak, Pakistan
N KHAN Khyber Medical college, Peshawar, Pakistan
KS KHAN Division of Vascular Surgery, Lady Reading Hospital Peshawar, Pakistan
H KHAN Khyber Medical college, Peshawar, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1096

Keywords:

Anticoagulation, Pregnancy Complications, Pulmonary Embolism, Thromboembolism, Venous Thrombosis

Abstract

Thromboembolism during pregnancy poses a significant challenge in maternal healthcare, substantially contributing to maternal morbidity and mortality worldwide. Understanding its diagnosis and management is crucial for improving maternal and fetal outcomes. Objective: To evaluate the diagnosis and management of thromboembolism in pregnant women. Methods: A retrospective cohort study was conducted at Lady Reading Hospital, Peshawar, from July 2022 to July 2024. The study included 175 pregnant females diagnosed with venous thromboembolism (VTE) during their pregnancy. Data were collected on patient demographics, trimester of diagnosis, type of thromboembolism (deep vein thrombosis [DVT] or pulmonary embolism [PE]), treatment modalities, and outcomes. Patients were treated with either low molecular weight heparin (LMWH) or unfractionated heparin (UFH). Descriptive statistics were used to analyze the data, with results presented as percentages and means with standard deviations. Results: The mean age of the participants was 32.01 ± 2.35 years. Thromboembolism was most commonly diagnosed in the third trimester (65%), followed by the second trimester (25%) and the first trimester (10%). DVT was observed in 74% of patients, while PE occurred in 26%. Among the 160 patients treated with LMWH, 3% (5 patients) experienced a recurrence of VTE. Of the 15 patients who received UFH, 5% (8 patients) had significant bleeding complications. Overall maternal outcomes included a 3% recurrence rate of VTE and a 5% rate of significant bleeding complications. No maternal mortality was reported. Conclusion: Early diagnosis and timely management of thromboembolism in pregnancy, mainly through the use of low molecular weight heparin and a multidisciplinary care approach, significantly improve maternal and fetal outcomes. LMWH was associated with fewer complications compared to UFH, highlighting its effectiveness and safety in treating pregnant women with VTE.

Downloads

Download data is not yet available.

References

Simcox LE, Ormesher L, Tower C, Greer IA. Pulmonary thrombo-embolism in pregnancy: diagnosis and management. Breathe. 2015;11(4):282-9.

Greer IA. Thrombosis in pregnancy: updates in diagnosis and management. Hematology 2010, the American Society of Hematology Education Program Book. 2012;2012(1):203-7.

Kearsley R, Stocks G. Venous thromboembolism in pregnancy—diagnosis, management, and treatment. BJA education. 2021;21(3):117-23.

Knight M, Bunch K, Tuffnell D, Jayakody H, Shakespeare J, Kotnis R, et al. Saving Lives, Improving Mothers’ Care-Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2014-16. 2018.

Leffert L, Butwick A, Carvalho B, Arendt K, Bates SM, Friedman A, et al. The Society for Obstetric Anesthesia and Perinatology consensus statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants. Anesthesia & Analgesia. 2018;126(3):928-44.

Touhami O, Marzouk SB, Bennasr L, Touaibia M, Souli I, Felfel MA, et al. Are the Wells Score and the Revised Geneva Score valuable for the diagnosis of pulmonary embolism in pregnancy? European Journal of Obstetrics & Gynecology and Reproductive Biology. 2018;221:166-71.

Yentis S, Lucas D, Brigante L, Collis R, Cowley P, Denning S, et al. Safety guideline: neurological monitoring associated with obstetric neuraxial block 2020: a joint guideline by the Association of Anaesthetists and the Obstetric Anaesthetists’ Association. Anaesthesia. 2020;75(7):913-9.

Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circulation research. 2016;118(9):1340-7.

Fukuda W, Chiyoya M, Taniguchi S, Daitoku K, Fukuda I. Management of deep vein thrombosis and pulmonary embolism (venous thromboembolism) during pregnancy. General thoracic and cardiovascular surgery. 2016;64:309-14.

Perisinakis K, Seimenis I, Tzedakis A, Damilakis J. Perfusion scintigraphy versus 256-slice CT angiography in pregnant patients suspected of pulmonary embolism: comparison of radiation risks. Journal of Nuclear Medicine. 2014;55(8):1273-80.

Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest. 2002;121(3):877-905.

Hobohm L, Keller K, Valerio L, Ni Ainle F, Klok FA, Münzel T, et al. Fatality rates and use of systemic thrombolysis in pregnant women with pulmonary embolism. ESC heart failure. 2020;7(5):2365-72.

Van Der Pol LM, Tromeur C, Bistervels IM, Ni Ainle F, Van Bemmel T, Bertoletti L, et al. Pregnancy-adapted YEARS algorithm for diagnosis of suspected pulmonary embolism. New England Journal of Medicine. 2019;380(12):1139-49.

Righini M, Robert-Ebadi H, Elias A, Sanchez O, Le Moigne E, Schmidt J, et al. Diagnosis of pulmonary embolism during pregnancy: a multicenter prospective management outcome study. Annals of internal medicine. 2018;169(11):766-73.

Barco S, Nijkeuter M, Middeldorp S, editors. Pregnancy and venous thromboembolism. Seminars in thrombosis and hemostasis; 2013: Thieme Medical Publishers.

Keller K, Hobohm L, Ebner M, Kresoja K-P, Münzel T, Konstantinides SV, et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. European heart journal. 2020;41(4):522-9.